Complete Scientific Guide to Iron

Iron is the most abundant element on Earth by mass and one of the most consequential nutrients in human biology. It carries oxygen in the blood, drives cellular energy production, supports DNA synthesis and neurotransmitter formation, and shapes how the immune system responds to infection. It is also the most common single nutrient deficiency worldwide, while at the same time being potentially toxic when too much accumulates. That narrow window between "not enough" and "too much" is why iron is among the most studied minerals in nutrition science.

This guide is a central, evidence-based reference on iron. It covers the chemistry, sources, history, mechanisms, absorption, clinical research, dosing, safety, quality, regulation and open questions, and it is written for readers who want the full scientific picture rather than a short summary. It is educational and does not replace medical advice. Anyone who suspects iron deficiency or iron overload should be tested before supplementing.

1. Executive Summary and Quick Facts

Iron (Fe, atomic number 26) is an essential trace mineral. An adult body holds roughly 3–4 grams, and about two thirds of it sits inside hemoglobin in red blood cells. The rest is stored as ferritin and hemosiderin, held in myoglobin in muscle, or built into hundreds of enzymes. The body has no regulated way to excrete iron, so balance is controlled almost entirely at the point of absorption through the hormone hepcidin.

Iron deficiency develops when intake, absorption or stores cannot keep up with needs or losses. It is most common in infants, adolescents, menstruating women, pregnant women, endurance athletes, people on plant-based diets and people with chronic blood loss or malabsorption. The evidence base is strongest for three uses: treating iron deficiency anemia, preventing anemia in pregnancy and infancy, and correcting iron deficiency in selected conditions such as heart failure and chronic kidney disease. Evidence is weaker or mixed for fatigue in non-anemic people, athletic performance, restless legs syndrome and cognition outside of deficiency.

Quick facts

Property	Detail
Name and symbol	Iron (Latin: ferrum), Fe, atomic number 26
Category	Essential trace mineral; transition metal
Biological forms	Ferrous (Fe2+), ferric (Fe3+), heme iron, non-heme iron
Total body content	About 3–4 g in adults
Core functions	Oxygen transport and storage, energy metabolism, DNA synthesis, neurotransmitter synthesis, immune function
US RDA (adults)	Men 8 mg/day; women 19–50 years 18 mg/day; women over 50 8 mg/day; pregnancy 27 mg/day
US Tolerable Upper Intake Level	45 mg/day for adults and teens aged 14 and over
Absorption	Heme iron about 15–35%; non-heme iron about 2–20%, depending on iron status and the meal
Master regulator	Hepcidin (liver hormone that blocks the iron exporter ferroportin)
Common supplement forms	Ferrous sulfate, fumarate, gluconate, bisglycinate, carbonyl iron, polysaccharide-iron complex, heme iron polypeptide, ferric maltol; intravenous iron by prescription
Typical doses in studies	30–60 mg elemental iron/day for prevention; about 40–200 mg/day for treatment under supervision
Main risks	Gastrointestinal upset; acute poisoning in young children; chronic overload in hemochromatosis; drug interactions
Strongest evidence	Iron deficiency anemia, pregnancy anemia prevention, infant anemia prevention, iron deficiency in heart failure

Key takeaways

•       Test first. Serum ferritin, hemoglobin and transferrin saturation tell you whether iron is needed. Supplementing without deficiency offers little proven benefit and carries risk.

•       Absorption, not just intake, determines outcome. Vitamin C and meat, fish and poultry help; tea, coffee, calcium and phytate-rich foods hinder.

•       Lower, less frequent doses are often absorbed better. Alternate-day dosing is supported by absorption studies and is often better tolerated.

•       Iron is a leading cause of poisoning in young children. Store supplements securely.

•       Iron overload is real. Hemochromatosis and repeated transfusion can cause serious organ damage, and these groups should not take iron supplements unless directed by a specialist.

2. Ingredient Definition and Identity

In nutrition science, "iron" refers to the element in any chemical form that the body can absorb and use. It is classed as an essential micronutrient because humans cannot synthesize it and must obtain it from food, fortified products or supplements. Without it, red blood cells cannot carry adequate oxygen, mitochondria cannot make energy efficiently, and cells cannot copy DNA at a normal rate.

On a supplement label, iron is declared as elemental iron, meaning the weight of the iron atom itself, not the weight of the whole compound. This distinction matters. A 325 mg tablet of ferrous sulfate contains about 65 mg of elemental iron, because ferrous sulfate is only about 20% iron by weight. A 325 mg tablet of ferrous fumarate contains about 106 mg, and a 325 mg tablet of ferrous gluconate contains about 38 mg. Dose comparisons between products are only meaningful on an elemental basis.

Two functional categories dominate the literature. Heme iron is iron held inside a porphyrin ring, found in hemoglobin and myoglobin and therefore in meat, poultry and fish. Non-heme iron is every other form: iron salts, iron chelates and the iron in plants, dairy, eggs and fortified foods. These categories differ in how they are absorbed, how strongly diet affects them and how they behave as supplements.

Iron also has a recognized identity as a "double-edged" nutrient. It is essential for life but, in free form, catalyzes reactions that generate damaging free radicals. For that reason the body binds iron to proteins at nearly every step: transferrin in blood, ferritin in storage, and heme or iron-sulfur clusters inside enzymes.

3. Botanical and Chemical Classification

Botanical classification

Iron has no botanical classification. It is a mineral, not a plant-derived compound. Plants do contain iron and some are used as dietary sources, such as legumes, leafy greens and seeds, but the iron itself is an inorganic element taken up from soil. Where plant sources matter, they are discussed under dietary origin and bioavailability.

Chemical classification

Iron is a d-block transition metal in group 8 and period 4 of the periodic table, with a standard atomic weight of about 55.85. It is a lustrous, ductile, magnetic metal in its elemental state. Its biological chemistry depends on its ability to shift easily between two oxidation states: ferrous (Fe2+) and ferric (Fe3+). That electron-transfer ability is what makes it useful in respiration and oxygen handling, and also what makes it hazardous when uncontrolled.

In nutrition and pharmacy, iron compounds are grouped as follows:

•       Ferrous salts: ferrous sulfate, ferrous fumarate, ferrous gluconate. Water-soluble or acid-soluble and widely used.

•       Ferric compounds: ferric pyrophosphate, ferric orthophosphate, ferric citrate, ferric maltol. Generally less soluble, though some are engineered for better absorption.

•       Iron chelates: ferrous bisglycinate (amino acid chelate), sodium iron EDTA (NaFeEDTA).

•       Polysaccharide and carbohydrate complexes: iron polymaltose, polysaccharide-iron complex, parenteral iron sucrose, ferric carboxymaltose and ferric derisomaltose.

•       Elemental iron powders: carbonyl, electrolytic and hydrogen-reduced iron.

•       Heme iron preparations: heme iron polypeptide made from animal hemoglobin.

Nutritionally, iron is a trace element required in milligram amounts per day, and it interacts with other minerals such as zinc, copper and manganese at the absorption stage.

4. Origin, Cultivation and Source

Cosmic and geological origin

Iron is formed in stars. Fusion in massive stars builds elements up to the iron group, where nuclear binding energy per particle peaks, and supernova explosions scatter iron into space. The Earth as a whole is about one third iron by mass, most of it in the core, while the crust is roughly 5% iron, making it the fourth most abundant crustal element. Principal ores include hematite (Fe2O3), magnetite (Fe3O4), goethite and siderite (FeCO3).

Dietary origin and soil uptake

Dietary iron originates in soil. Plants absorb iron from the rhizosphere using specialized strategies and store it in seeds and leaves, and animals concentrate it in blood and muscle. Iron content in a crop depends on soil chemistry, pH and variety, and phytic acid in the same crop can reduce how much of that iron humans absorb.

Major food sources

•       Heme sources: liver, oysters, clams, sardines, beef, lamb and dark poultry meat. Three ounces of cooked beef provides roughly 2 mg; oysters and organ meats can provide considerably more.

•       Non-heme plant sources: lentils, chickpeas and beans, tofu, pumpkin and sesame seeds, spinach, quinoa, amaranth and dark chocolate. A half cup of cooked lentils provides around 3 mg.

•       Fortified foods: breakfast cereals, flours, rice and salt in many national programs; some fortified cereals deliver 18 mg per serving.

•       Cookware: cooking acidic foods in cast iron can measurably raise the iron content of the meal.

Biofortification

Plant breeding has produced iron-biofortified crops, notably beans and pearl millet. Controlled feeding trials in Rwandan women and in school children in India found that iron-biofortified beans and pearl millet improved measures of iron status relative to conventional varieties, supporting biofortification as a food-based strategy where supplements are hard to deliver.

Manufacture of supplement ingredients

Supplement iron salts are typically produced industrially. Ferrous sulfate is often obtained as a by-product of steel pickling or titanium dioxide production and then purified. Carbonyl iron is made by thermal decomposition of iron pentacarbonyl. Chelates such as bisglycinate are produced by reacting an iron salt with the amino acid glycine under controlled conditions. Heme iron preparations derive from animal blood.

5. History and Traditional Use

Iron has been used in medicine for thousands of years. Ancient Greek tradition recounts the physician-seer Melampus treating a prince with wine in which iron rust had been steeped, and Roman authors recorded iron preparations for weakness and pallor. In Ayurveda, calcined iron preparations known as lauha bhasma have long been used for pallor, weakness and what is now recognized as anemia. Traditional Chinese medicine and Unani practice also used iron-containing mineral preparations. These traditional uses reflected genuine observation of pale, tired patients, though the preparations were of unreliable composition.

In the seventeenth century the English physician Thomas Sydenham described treating "chlorosis" (the green sickness of young women) with iron filings steeped in wine. In 1713 French chemists detected iron in blood ash, and in the eighteenth century the Italian physician Vincenzo Menghini showed that iron is a constituent of blood. In 1832 Pierre Blaud introduced Blaud's pills, a mixture of ferrous sulfate and potassium carbonate for chlorosis, which became one of the first scientifically targeted iron therapies.

The twentieth century clarified how the body handles iron. In 1937 McCance and Widdowson showed that humans regulate iron balance by controlling absorption and not by excreting excess, which is a foundational principle of iron physiology. Public health responded with food fortification: the United Kingdom fortified flour during the Second World War and the United States introduced enriched flour in 1941.

The molecular era followed. Transferrin, ferritin and the transferrin receptor were characterized in the mid-twentieth century. The hormone hepcidin was reported in 2000–2001, and in 2004 Nemeth and colleagues showed that it binds ferroportin and triggers its internalization. This discovery, along with the later identification of erythroferrone, finally explained how the body senses and balances iron, and it reshaped dosing strategies and the understanding of anemia of inflammation. The twenty-first century has added intravenous iron formulations, hepcidin-informed dosing and an appreciation that iron deficiency, with or without anemia, deserves treatment on its own terms.

6. Modern Nutraceutical Use

Iron is among the most widely used mineral supplements and fortificants in the world. Its modern uses fall into several categories.

•       Treatment of deficiency: prescribed or recommended for iron deficiency and iron deficiency anemia, usually as oral ferrous salts, with intravenous iron when oral therapy fails or is not tolerated.

•       Prenatal and postnatal care: most prenatal vitamins contain iron, and many guidelines advise daily or intermittent iron for pregnant women where anemia is common.

•       Infant and child nutrition: drops and syrups for breastfed infants, fortified formula and fortified complementary foods.

•       Women's health: support for heavy menstrual blood loss, adolescence and the postpartum period.

•       Sports nutrition: correction of iron deficiency in endurance athletes, particularly female athletes.

•       Plant-based diets: supplementation or fortified foods for vegetarians and vegans, who may need up to 1.8 times the standard intake because non-heme iron is absorbed less efficiently.

•       Large-scale public health: fortification of flour, rice, salt and condiments, and national supplementation programs such as India's Anemia Mukt Bharat initiative.

Product innovation has focused on tolerability and absorption. "Gentle iron" products use ferrous bisglycinate, lower doses, liposomal or sucrosomial formats, and combinations with vitamin C, folate or vitamin B12. Heme iron products and lactoferrin-based products also occupy a niche. Consumers should note that many of these claims rest on small studies, and that tolerability marketing does not replace the need for confirmed deficiency and monitored treatment.

7. Chemical Composition

Elemental and compound composition

Pure iron is a single element, but in practice it is consumed as compounds whose iron content varies widely. The table below shows approximate elemental iron content by weight for common supplement and fortificant forms.

Compound	Approximate elemental iron	Notes
Ferrous sulfate (dried)	30%	Reference compound for most absorption comparisons
Ferrous sulfate heptahydrate	20%	Common 325 mg tablet gives about 65 mg iron
Ferrous fumarate	33%	High iron density; used in tablets and fortification
Ferrous gluconate	12%	Low iron density; 325 mg gives about 38 mg
Ferrous bisglycinate	About 20%	Amino acid chelate
Ferric pyrophosphate	About 25%	Poorly soluble; used in fortification where color and taste matter
Carbonyl iron	About 98–99%	Fine elemental powder, slow dissolving
NaFeEDTA	About 13%	Fortificant with enhanced absorption from phytate-rich meals

Biological iron compounds

Inside the body iron exists in tightly defined molecular settings. Hemoglobin is a tetramer carrying four heme groups, and each heme is a protoporphyrin IX ring holding one ferrous ion. One gram of hemoglobin contains about 3.4 mg of iron, and a liter of blood contains roughly 500 mg. Myoglobin carries one heme and stores oxygen in muscle. Transferrin is a plasma glycoprotein that binds up to two ferric ions and delivers them to cells. Ferritin is a hollow protein shell of 24 subunits that can store thousands of iron atoms in a safe, soluble mineral core. Hemosiderin is a denatured, aggregated storage form seen when iron stores are high.

Iron in food matrices

In food, iron is mixed with compounds that alter its behavior. Ascorbic acid, organic acids and muscle protein promote solubility. Phytate, polyphenols, calcium and some proteins bind or block it. The same quantity of iron can therefore deliver very different amounts to the body depending on the meal, which is why chemical composition alone does not predict nutritional value.

8. Key Active Compounds

Iron acts through the molecules that contain it. The most important are listed here.

•       Hemoglobin: carries oxygen from lungs to tissues. About 65–70% of body iron is here.

•       Myoglobin: stores and releases oxygen in muscle, accounting for roughly 10% of body iron.

•       Cytochromes and iron-sulfur proteins: electron carriers in mitochondrial complexes I, II and III and in cytochrome oxidase. They drive ATP production.

•       Ribonucleotide reductase: an iron-dependent enzyme needed to make the building blocks of DNA.

•       Catalase and peroxidases: iron-containing enzymes that neutralize hydrogen peroxide.

•       Cytochrome P450 enzymes: heme proteins that metabolize drugs, hormones and toxins.

•       Iron-dependent dioxygenases: include prolyl hydroxylases that regulate collagen formation and the oxygen-sensing HIF pathway, and enzymes that modify DNA and histones.

•       Neurotransmitter enzymes: tyrosine hydroxylase (dopamine, noradrenaline) and tryptophan hydroxylase (serotonin) require iron.

•       Transferrin and transferrin receptor 1: transport and uptake machinery.

•       Ferritin and hemosiderin: storage proteins that also serve as an indicator of body stores.

•       Lactoferrin: an iron-binding glycoprotein in milk and secretions that contributes to antimicrobial defense.

•       Hepcidin and ferroportin: the regulatory hormone and its target, which control absorption and release.

Free, unbound iron is not an active compound but a hazard. The Fenton reaction, in which ferrous iron reacts with hydrogen peroxide to produce highly reactive hydroxyl radicals, explains much of iron's toxicity and why the body binds iron so carefully.

9. Extraction and Processing

Source materials and refining

Commercial iron salts begin with metallic iron or iron-rich solutions. Ferrous sulfate is generated by dissolving iron in sulfuric acid or recovered as a by-product of industrial pickling, then crystallized and dried. Ferrous fumarate is produced by reacting a ferrous salt with fumaric acid. Chelates are made by reacting ferrous salts with glycine or other amino acids. Carbonyl iron is produced by forming iron pentacarbonyl and decomposing it to yield very fine, high-purity iron spheres. Electrolytic and hydrogen-reduced iron are produced by electrodeposition or reduction of iron oxides.

Heme iron and biological sources

Heme iron polypeptide is prepared from animal hemoglobin, typically bovine or porcine, by enzymatic hydrolysis followed by purification and drying. Because it originates from animals, it is unsuitable for vegetarians, and product consistency depends on the source and process.

Formulation technologies

Formulation addresses the main problems of oral iron: taste, color, gastric irritation and interactions in food.

•       Microencapsulation: coats iron particles, for example with lipids, to mask metallic taste and reduce interaction with food ingredients.

•       Sucrosomial technology: ferric pyrophosphate protected by a phospholipid and sucrester matrix, developed to improve tolerability.

•       Controlled and delayed release: can reduce stomach irritation, though iron is absorbed mainly in the duodenum, so delayed release and enteric coating may lower absorption.

•       Particle-size reduction: nano-sized ferric phosphate and pyrophosphate are under study for fortification of difficult foods.

•       Co-formulation: pairing iron with ascorbic acid, folate, B12 or other nutrients.

Fortification premixes

For public health fortification, iron is blended into premixes with other nutrients and added to flour, rice or salt at defined levels. Choices are driven by sensory impact: highly soluble salts such as ferrous sulfate may cause rancidity or color changes in some foods, while poorly soluble forms such as elemental iron and ferric pyrophosphate are inert but less bioavailable. NaFeEDTA is used where phytate is abundant, such as with cereal and soy-based foods. India's double-fortified salt, which delivers iodine and iron, is an example of a technology adapted to local diets.

10. Standardization and Potency

How iron is standardized

Unlike botanical extracts that are standardized to marker compounds, iron is standardized by elemental iron content per dose. A reliable product states the amount of elemental iron, ideally also the source compound, and delivers that amount within an accepted tolerance of the label claim over its shelf life.

Analytical methods and pharmacopeial standards

Potency is usually verified by atomic absorption spectroscopy, ICP-OES or ICP-MS after acid digestion. Pharmacopeial monographs, including those of the United States Pharmacopeia and the British and European pharmacopoeias, define identity tests, assay limits, dissolution or disintegration requirements and limits on impurities for ferrous sulfate, fumarate and gluconate. Ferrous iron content, as distinct from total iron, matters because oxidation to ferric iron during storage can reduce absorption of ferrous products. Heme iron preparations are standardized to heme iron content rather than total iron.

Label conventions

In the United States, the Daily Value for iron is 18 mg, and labels list elemental iron and percent Daily Value. In the European Union, the nutrient reference value is 14 mg. Because these differ, percentages on labels are not comparable across markets; mg of elemental iron is the reliable figure.

What potency does and does not tell you

Potency measures amount, not effect. Two products with equal elemental iron can differ in absorption by a factor of several, depending on chemical form, particle size, dissolution, coating and the other ingredients included. Dissolution testing helps, but human absorption data remain the best measure of real-world performance.

11. Mechanisms of Action

Intestinal absorption

Most dietary iron is absorbed in the duodenum and upper jejunum. Non-heme iron is mostly ferric in the diet, so it must first be reduced to ferrous iron by duodenal cytochrome B (Dcytb) and by dietary reducing agents such as ascorbic acid. Ferrous iron then enters enterocytes through divalent metal transporter 1 (DMT1). Heme iron is taken up as an intact molecule by a pathway that is not fully defined, and iron is released from heme inside the cell by heme oxygenase.

Inside the enterocyte iron is either stored in ferritin and lost when the cell sheds, or exported across the basolateral membrane by ferroportin. A copper-containing ferroxidase, hephaestin, oxidizes it to ferric iron so that transferrin can bind it. This is one reason copper status matters for iron metabolism.

Systemic distribution and recycling

Transferrin carries iron to cells, which take it up through transferrin receptor 1 by endocytosis. Developing red cells in bone marrow are the dominant consumers, using about 20–25 mg per day. Most of this iron is recycled: macrophages in the spleen and liver engulf aging red cells, release iron from heme and return it to circulation through ferroportin. New dietary iron supplies only about 1–2 mg a day.

Hepcidin: the master regulator

Hepcidin, a peptide produced by the liver, binds ferroportin and causes it to be internalized and degraded. Less ferroportin means less iron absorbed from the gut and less iron released from macrophages and stores. Hepcidin rises when iron stores are high, through the BMP-SMAD pathway involving HFE, transferrin receptor 2 and hemojuvelin, and during inflammation, through interleukin-6. It falls when iron is scarce, when hypoxia is present, and when the bone marrow demands iron, in part through the hormone erythroferrone. This system explains anemia of inflammation, where iron is present but trapped, and iron-refractory anemias caused by mutations such as those in TMPRSS6.

Cellular iron control

Inside cells, iron regulatory proteins sense iron and bind iron-responsive elements on messenger RNA. When iron is low, ferritin translation is suppressed and transferrin receptor mRNA is stabilized, so cells take up more iron and store less. When iron is high, the reverse occurs.

Functional mechanisms

Iron's functional roles are chemical: it binds oxygen reversibly in heme, shuttles electrons in the respiratory chain, and serves as a cofactor for enzymes in DNA synthesis, collagen formation, hormone and neurotransmitter synthesis and oxygen sensing. Iron deficiency therefore reduces oxygen delivery and impairs tissue energy metabolism at the same time.

Iron toxicity and ferroptosis

When iron exceeds the binding capacity of transferrin, non-transferrin-bound iron enters tissues and catalyzes oxidative damage. A form of regulated cell death driven by iron-dependent lipid peroxidation, called ferroptosis, was described in 2012 and is now studied in cancer, neurodegeneration and ischemic injury.

12. Pharmacokinetics

Absorption

Fractional absorption is not fixed. In iron-replete adults, absorption from supplements is usually in the range of a few percent to about 10–15%, while iron-depleted individuals may absorb 20% or more of a small dose. Because the dose-response curve flattens quickly, larger doses mainly increase unabsorbed iron in the gut and side effects. After an oral dose, serum iron typically peaks within about two to four hours.

Distribution

Absorbed iron binds to transferrin, which normally is only about 20–45% saturated. The plasma contains only about 3 mg of iron at any time but turns over many times daily; the plasma iron half-life is in the order of one to one and a half hours. Iron is then distributed mainly to bone marrow for hemoglobin, with the rest to the liver, muscle and other tissues.

Storage and metabolism

Excess iron is stored as ferritin and hemosiderin, mainly in the liver, spleen and bone marrow. Typical stores are about 1 g in men and 0.2–0.4 g in premenopausal women. Iron is not metabolized in the sense of being broken down; it is recycled, with red blood cells living for about 120 days.

Elimination

There is no regulated excretory pathway. Losses of about 1–2 mg per day occur through shedding of intestinal and skin cells, small amounts in urine and sweat, and menstruation, which averages roughly 0.5 mg per day over the cycle but ranges widely. A standard blood donation removes about 200–250 mg of iron. Pregnancy requires a total of roughly 1,000 mg over its course, with needs rising to 4–6 mg per day in the second and third trimesters.

Pharmacokinetics of intravenous iron

Parenteral iron is taken up by macrophages, which process the carbohydrate shell and release iron to transferrin. Half-lives range from several hours for iron sucrose to roughly a day for ferric derisomaltose, and the formulations differ in how much can be given in a single infusion, from a few hundred milligrams to 1,000 mg or more.

The hepcidin effect on dosing

A dose of iron raises serum hepcidin within hours, and the elevation can persist for up to about 24 hours, reducing absorption of any further dose in that window. Hepcidin also follows a daily rhythm, generally lower in the morning and higher later in the day. These observations underpin the interest in morning, once-daily and alternate-day dosing.

13. Bioavailability

Heme versus non-heme

Heme iron is absorbed at roughly 15–35% and is relatively unaffected by other dietary components, apart from calcium, which can reduce it in some studies. Non-heme iron absorption varies from below 2% to about 20%, controlled by iron status and the dietary matrix. Even though heme provides only a minor proportion of dietary iron in many diets, it can account for a disproportionate share of absorbed iron.

Dietary enhancers

•       Ascorbic acid: reduces ferric to ferrous iron and forms a soluble chelate. It markedly increases non-heme absorption in single meals, although long-term studies that add vitamin C to a complete diet show smaller effects.

•       Meat, fish and poultry factor: muscle tissue enhances absorption of non-heme iron eaten at the same meal.

•       Organic acids and fermentation: citric, lactic and malic acids can help; fermentation and sprouting reduce phytate.

Dietary inhibitors

•       Phytates: found in whole grains, legumes, nuts and seeds. Even small amounts reduce absorption, and the effect is dose-dependent.

•       Polyphenols: tannins in tea, and compounds in coffee, cocoa and some herbs. Classic studies found that coffee reduced non-heme absorption from a meal by about 40% and tea by more than 60%.

•       Calcium: inhibits both heme and non-heme iron in single-meal studies, though long-term effects on iron status appear small.

•       Soy protein, egg phosvitin and some fibers: reduce absorption.

•       Zinc and manganese: can compete with iron at high supplemental doses.

Host factors

Iron deficiency and low hepcidin increase absorption. Inflammation, infection and iron-replete status reduce it. Gastric acid helps solubilize iron, so acid-suppressing drugs, atrophic gastritis and Helicobacter pylori infection can lower absorption. Gut conditions such as celiac disease and inflammatory bowel disease, and surgeries such as gastric bypass, reduce absorption surface or contact.

Comparing supplement forms

Ferrous salts are the benchmark. Ferric salts are typically absorbed less well, and elemental powders and poorly soluble ferric phosphates have variable and often lower relative bioavailability. Ferrous bisglycinate has shown higher absorption than ferrous sulfate in some fortification studies, particularly with phytate-rich food, with reports in the range of two- to four-fold under certain conditions, but head-to-head clinical outcome data are more limited. NaFeEDTA is absorbed well from phytate-rich meals. Evidence for sucrosomial and liposomal iron is promising but still comparatively small.

14. Preclinical Evidence Summary

Preclinical research on iron is extensive and has established the main principles of iron biology, although it should be interpreted with caution because rodent iron handling differs in important ways from human physiology.

Animal and genetic models

Knockout and mutant mice have defined the iron pathway. Loss of hepcidin causes severe iron overload, mimicking juvenile hemochromatosis, while hepcidin overexpression causes iron-restricted anemia. Mice lacking DMT1 or ferroportin in the intestine develop severe iron deficiency, confirming those proteins as the main gateways. Mutations in TMPRSS6 produce a human and mouse phenotype of iron-refractory iron deficiency anemia, which clarified how hepcidin is suppressed. Dietary iron restriction in young animals produces anemia, reduced growth and impaired myelination.

Neurodevelopment

Iron-deficient rodent and primate models show reduced brain iron, altered dopamine signaling, disturbed myelination and abnormal hippocampal development, with some behavioral effects persisting after iron repletion if deficiency occurred early. This work is the biological basis for concern about iron deficiency in infancy and has been summarized in the context of dopaminergic dysfunction.

Cell-based studies

In cell culture, iron supports proliferation, and iron chelation arrests the cell cycle by inhibiting ribonucleotide reductase. Excess iron drives lipid peroxidation, and inhibitors of ferroptosis protect cells in models of ischemia, neurodegeneration and kidney injury. Cancer cells often show high iron demand, which has led to research on iron-targeted therapies.

Infection and immunity

Preclinical and mechanistic data show that pathogens compete with the host for iron. The host responds by raising hepcidin, producing lactoferrin and lipocalin-2, and sequestering iron, a defense sometimes called nutritional immunity. Many bacteria and malaria parasites depend on iron availability, which is the mechanistic background to the debate on iron supplementation in infection-prone settings.

Gut microbiome

Animal and some infant studies suggest unabsorbed iron may shift gut microbial composition toward more iron-using, potentially pathogenic organisms and alter gut inflammation. Findings in Kenyan infants given iron-fortified food supported this concern, though effects in other settings and with different iron forms are less clear.

Limitations

Preclinical studies often use high doses, short durations and species with different absorption control. They explain mechanism well but cannot establish clinical dose, safety or efficacy in humans.

15. Human Clinical Evidence Summary

Iron deficiency anemia in adults

Randomized trials and systematic reviews consistently show that oral iron raises hemoglobin and ferritin compared with placebo, usually by about 1–2 g/dL over several weeks, with ferritin rebuilding more slowly. Intravenous iron produces faster and larger increases in hemoglobin and stores than oral iron in many settings, particularly in inflammatory bowel disease, chronic kidney disease, heavy bleeding, postpartum anemia and intolerance of oral iron. Reviews report more gastrointestinal adverse effects with oral iron and more rare hypersensitivity-type reactions and, with some preparations, hypophosphatemia with intravenous iron.

Pregnancy

A Cochrane review of daily oral iron during pregnancy found large reductions in maternal anemia at term, in the region of a 70% reduction in risk, as well as lower rates of iron deficiency and iron deficiency anemia. Effects on low birth weight were modest in some analyses, and clear effects on preterm birth, infant mortality or maternal outcomes such as infection were less certain. WHO recommends daily iron and folic acid in pregnancy, with intermittent regimens as an alternative when daily doses are poorly tolerated.

Infants and children

A meta-analysis of daily iron in children aged 4–23 months found substantial reductions in anemia and iron deficiency and increases in hemoglobin. Evidence for developmental benefit is stronger in children with deficiency than in iron-replete children. A large trial in Pemba, Tanzania, found that routine iron and folic acid in a high-malaria setting increased hospital admissions and deaths in children who were not iron deficient, which led WHO to advise caution and linkage with malaria control in endemic areas. The American Academy of Pediatrics recommends iron for exclusively breastfed infants from four months and for preterm infants from one month, until iron-rich complementary foods are established.

Fatigue and non-anemic iron deficiency

A randomized, placebo-controlled trial in menstruating women with unexplained fatigue and low ferritin (50 µg/L or less, no anemia) found that ferrous sulfate for 12 weeks reduced fatigue more than placebo, roughly 48% versus 29% in the original report. A meta-analysis of trials in non-anemic iron-deficient adults reported reductions in fatigue and some improvement in physical performance, though the quality of trials varies. Iron in people with normal iron status does not improve fatigue.

Exercise and athletic performance

Iron deficiency impairs endurance and aerobic capacity, and correcting anemia improves performance. Evidence for benefit in non-anemic iron-deficient athletes is mixed and depends on baseline stores and training load. Exercise itself raises hepcidin for several hours, which may limit absorption after training, so timing matters.

Cognition and mental health

In iron-deficient children and adolescents, iron improves some cognitive and attention measures. In iron-replete people, benefit has not been shown. Observational links between low ferritin and ADHD, depression or postpartum mood changes exist, but trials are small and results inconsistent.

Heart failure

In patients with heart failure with reduced ejection fraction and iron deficiency (typically ferritin under 100 µg/L, or 100–299 µg/L with transferrin saturation under 20%), intravenous ferric carboxymaltose in FAIR-HF improved symptoms, functional capacity and quality of life. Later trials, including AFFIRM-AHF, IRONMAN and HEART-FID, reported reductions in heart failure hospitalization in some analyses, while effects on cardiovascular death were not consistently demonstrated, and primary endpoints in some trials narrowly missed conventional significance. Current US heart failure guidance considers intravenous iron reasonable in this population to improve functional status and quality of life. Oral iron has not shown comparable benefit in heart failure trials.

Restless legs syndrome

Iron deficiency in the brain is implicated in restless legs syndrome. Guidelines suggest checking ferritin and considering iron when levels are low, often with a threshold of about 75 µg/L. Evidence for intravenous iron is moderate, with mixed results across formulations and lower certainty for oral iron.

Chronic kidney disease, inflammatory bowel disease and surgery

Intravenous iron is established in CKD, IBD and cancer-related anemia, and is increasingly used before surgery to reduce anemia and, in some trials, transfusion. These indications are managed by specialists.

Iron and infection, cancer and metabolic outcomes in observational data

Observational studies link high heme iron intake and high ferritin with higher type 2 diabetes risk and, in some reports, colorectal cancer, but these associations are confounded by diet, inflammation and obesity, since ferritin rises with inflammation, and they do not prove causation.

16. Evidence Grading by Outcome

The table below is an editorial grading, using a simplified GRADE-style framework, based on the quality, consistency and directness of the human evidence summarized in this guide. It is a communication tool and not a formal guideline.

Outcome	Population	Evidence grade	Comment
Raising hemoglobin and ferritin	Adults with iron deficiency anemia	Strong	Consistent randomized evidence for oral and IV iron
Preventing anemia in pregnancy	Pregnant women	Strong	Large reductions in anemia at term
Preventing anemia and iron deficiency	Infants and young children	Moderate to strong	Malaria-endemic setting caveat
Reducing fatigue	Iron-deficient, non-anemic women	Moderate	Benefit depends on low baseline stores
Endurance and exercise capacity	Iron-deficient athletes	Moderate for anemia; low for non-anemic deficiency	Mixed trials, small samples
Cognition and development	Iron-deficient children	Moderate	Weaker for iron-replete children
Symptoms and hospitalization	Heart failure with iron deficiency (IV iron)	Moderate	Mortality benefit uncertain
Restless legs syndrome	Adults with low ferritin	Low to moderate	Better for IV than oral iron
ADHD symptoms	Children with low ferritin	Low	Small, inconsistent studies
Immune function and infection	General	Low and mixed	Deficiency impairs immunity; excess may favor some pathogens
Hair loss	Women with low ferritin	Low	Limited trials
Any benefit from supplementing	Iron-replete adults	Not supported	Risk of side effects and iron accumulation

17. Dosages Used in Studies

Dosing should always be expressed as elemental iron and individualized after testing. The ranges below reflect doses in guidelines and trials, not recommendations for self-treatment.

Context	Typical studied or recommended dose (elemental iron)	Notes
Dietary reference intake, adults	8 mg/day (men and women over 50); 18 mg/day (women 19–50)	US RDA; vegetarians about 1.8 times higher
Pregnancy, intake	27 mg/day	US RDA
Pregnancy, prevention	30–60 mg/day	WHO
Pregnancy, treatment of anemia	Up to 120 mg/day under supervision	WHO guidance; lower daily or alternate-day doses are increasingly used
Adult women, prevention in high-prevalence settings	30–60 mg/day, or 60 mg once weekly intermittently	WHO
Adult iron deficiency anemia, treatment	About 40–200 mg/day, with 40–80 mg once daily or on alternate days now favored	Older practice used 100–200 mg split doses
Breastfed infants, prevention	1 mg/kg/day from 4 months	AAP
Preterm infants	2 mg/kg/day from 1 month	AAP
Children, treatment of IDA	About 3 mg/kg/day	AAP
Intravenous iron	Individualized by iron deficit; 200–1,000 mg per infusion, depending on product	Prescription only
Tolerable Upper Intake Level	45 mg/day (adults and teens 14+); 40 mg/day (children under 14)	Applies to non-medical use

Several studies show that higher doses do not proportionately increase absorption. In young women, doses of 60 mg or more raised hepcidin and reduced absorption from subsequent doses, and split dosing did not improve absorption. Elderly patients have been successfully treated with low doses of around 15–50 mg/day with fewer side effects. In prolonged treatment, iron is typically continued for about three months after hemoglobin normalizes to replenish stores, with ferritin checked to guide stopping.

18. Timing and Use

Best timing

Iron is best absorbed on an empty stomach, but that also produces more nausea. Many clinicians suggest taking it with a small amount of food if the stomach is sensitive, accepting some loss of absorption. A morning dose takes advantage of the lower morning hepcidin level. After a dose, hepcidin rises for roughly a day, so taking iron every other day gives hepcidin time to fall and has been shown to increase fractional absorption, in one study by about one third compared with consecutive days. Later trials have shown that alternate-day dosing performs similarly to daily dosing for repleting iron and is often better tolerated, though results are not uniform.

What to take it with

•       Vitamin C: a vitamin C-rich food or drink with the dose improves absorption in single-dose studies. Clinical benefit of adding vitamin C tablets has been smaller than expected.

•       Foods to separate from dose: tea, coffee, milk and calcium supplements, antacids, high-fiber cereals and soy should be kept at least one to two hours apart from the iron dose.

•       Medicines: many drugs chelate iron or are impaired by it, and spacing instructions are in section 21.

For athletes

Because hepcidin rises after exercise, a morning dose before training or a dose at least a few hours after exercise has been proposed as a way to protect absorption, based on small studies.

Duration

Ferritin and hemoglobin should be rechecked about four to eight weeks after starting. Hemoglobin typically improves within two to four weeks. Therapy usually continues for about three months after hemoglobin normalizes to replace stores. Persistent deficiency should prompt investigation for blood loss, malabsorption or non-adherence.

Managing side effects

Lowering the dose, switching to alternate-day dosing, taking with food, or changing to a different salt or formulation are common strategies. Stool darkening is expected and harmless, but black, tarry, sticky stools with abdominal pain suggest bleeding and need medical attention.

19. Available Forms

Form	Examples	Strengths	Limitations
Ferrous sulfate	Tablets, syrups, drops	Inexpensive, well studied, reference standard	Most gastrointestinal side effects
Ferrous fumarate	Tablets, suspensions	High elemental iron, inexpensive	Similar side effects to sulfate
Ferrous gluconate	Tablets, liquids	Often considered milder	Low iron content per tablet
Ferrous bisglycinate	Capsules, powders	Good tolerability; good absorption in food studies	More costly; fewer clinical outcome trials
Carbonyl iron	Tablets, fortification	Slow release, low acute toxicity	Slower repletion in some studies
Polysaccharide-iron complex	Capsules	Tolerability claims	Variable absorption data
Iron polymaltose	Syrups, tablets	Widely used outside the US	Some trials show less effective than ferrous salts
Heme iron polypeptide	Tablets	High absorption; less affected by inhibitors	Animal origin; cost
Ferric maltol	Capsules	Useful in IBD and ferrous-salt intolerance	Cost; prescription in many markets
Ferric citrate	Tablets	Used in CKD	Medical use
Sucrosomial and liposomal iron	Capsules, sachets	Tolerability claims	Limited clinical outcome data
NaFeEDTA, ferric pyrophosphate, elemental powders	Food fortification	Stable in food; WHO-endorsed options	Variable bioavailability
Intravenous iron	Iron sucrose, ferric carboxymaltose, ferric derisomaltose, ferumoxytol, low-molecular-weight iron dextran	Rapid repletion, bypasses the gut	Infusion reactions (rare), hypophosphatemia with some forms; requires supervision

Choice of form should be driven by diagnosis, severity, tolerance, cost and access. For most uncomplicated cases, a ferrous salt remains first line. Enteric-coated and extended-release products may be gentler but can reduce absorption, and chewables, gummies and liquids vary widely in actual iron content and should be checked for elemental iron on the label.

20. Safety and Side Effects

Common adverse effects

Oral iron commonly causes nausea, abdominal discomfort, constipation, diarrhea, a metallic taste and dark stools. A systematic review found that ferrous sulfate roughly doubled the likelihood of gastrointestinal side effects compared with placebo, and these effects are a leading reason people stop treatment. They are dose-related and generally lessen with lower or alternate-day dosing. Liquid iron can stain teeth, and rarely pill-induced esophageal or gastric injury occurs, especially in older adults who take tablets without enough fluid.

Acute iron poisoning

Iron is a leading cause of poisoning deaths in young children. Toxicity depends on elemental iron per kilogram of body weight: below about 20 mg/kg symptoms are unlikely, 20–60 mg/kg may cause significant gastrointestinal and systemic effects, and doses above about 60 mg/kg can be life threatening. Poisoning follows stages: gastrointestinal irritation with vomiting and bleeding, an apparent latent recovery, shock with metabolic acidosis, liver injury, and later gastrointestinal scarring. Treatment is emergency care and may include chelation with deferoxamine. In the United States, iron-containing supplements must carry a prominent child-poisoning warning, and products with 30 mg or more of iron per dose unit must use unit-dose packaging. Families should store all iron products, including prenatal vitamins and gummies, out of reach and call poison control or emergency services immediately if a child swallows any.

Chronic iron excess

Hereditary hemochromatosis, most often caused by homozygous C282Y variants in the HFE gene, leads to uncontrolled absorption and organ iron deposition. It affects roughly 1 in 200–300 people of northern European ancestry and is treated by regular phlebotomy. Iron overload also occurs with repeated transfusions or in some chronic anemias with ineffective red cell production, such as thalassemia. In these conditions, iron supplements and, in some cases, vitamin C and iron-fortified products should be avoided unless instructed by a specialist.

Questions about long-term moderate excess

Large observational studies associate high ferritin and heme iron intake with cardiometabolic disease, but ferritin is also an inflammation marker and diet patterns are confounders. Iron accumulation in the brain is observed in neurodegenerative diseases, but whether it is cause or consequence is debated, and a trial of an iron chelator in early Parkinson's disease worsened outcomes, which shows that biology is not simple. The practical conclusion is conservative: correct deficiency, avoid unneeded supplements, and monitor if long-term therapy continues.

Other considerations

•       Infection: in malaria-endemic and infection-prone settings, supplementation should be paired with infection control, in line with WHO guidance.

•       Intravenous iron: serious hypersensitivity reactions are rare with modern products. Ferric carboxymaltose is associated with hypophosphatemia in a meaningful minority of patients, which is usually transient but can become symptomatic.

•       Allergy: true allergy to oral iron is rare; most reported "allergies" are intolerance.

•       Pregnancy and breastfeeding: iron is generally safe at recommended doses, but only a clinician should prescribe higher doses.

21. Drug and Supplement Interactions

Iron can bind to or interfere with some medicines, and some medicines or conditions impair iron absorption. Spacing is the usual solution, but the exact interval should follow the product label or a pharmacist's advice.

Interacting agent	Effect	Common practical advice
Levothyroxine	Iron binds the drug and lowers absorption	Separate by at least 4 hours
Fluoroquinolones (for example ciprofloxacin)	Chelation reduces antibiotic absorption	Take antibiotic well before or after iron, per label
Tetracyclines (doxycycline, minocycline)	Mutual reduction in absorption	Separate by 2–3 hours or as labeled
Levodopa/carbidopa	Iron can reduce levodopa absorption	Separate and monitor symptoms
Penicillamine, methyldopa	Reduced drug absorption	Separate doses
Bisphosphonates	Reduced absorption	Follow strict bisphosphonate instructions
Integrase inhibitors (such as dolutegravir)	Chelation with iron	Take with food together or separate as labeled
Proton pump inhibitors, H2 blockers, antacids	Reduce gastric acidity and iron absorption	Consider dosing, form or IV iron if long term
Calcium, magnesium and zinc supplements	Competition or binding	Separate by 2 hours; high-dose zinc in particular
Vitamin C	Increases absorption	Helpful when timed together
NSAIDs and aspirin	May cause gastrointestinal blood loss over time	Relevant when iron deficiency is unexplained
Chelators (deferasirox, deferoxamine, deferiprone)	Remove iron	Used for overload, not combined with iron supplements
Copper deficiency	Impairs iron export	Check copper status if iron-refractory anemia
Tea, coffee, high-fiber and soy foods	Reduce absorption	Keep two hours apart

Vitamin A and riboflavin deficiency can worsen anemia, and vitamin B12 and folate deficiency can cause anemia that is not iron responsive. Patients taking several medicines should confirm timing with a pharmacist.

22. Special Populations

Infants and young children

Term infants are born with iron stores that last roughly four to six months, after which breast milk alone provides too little. Rapid growth makes toddlers vulnerable. Iron is vital for brain development, and screening and supplementation guidance is set by pediatric bodies. Doses should be weight based and given by clinician instruction, with iron products kept away from children.

Adolescents

Growth spurts, the onset of menstruation, restrictive diets and sports raise needs. Adolescent girls are among the highest-risk groups, which is why school-based weekly iron and folic acid programs are used in some countries, including India.

Women of reproductive age

Menstrual blood loss is the most common cause of deficiency in this group. Heavy periods, defined clinically by large clots, flooding, or changing protection very often, should be assessed and managed alongside iron replacement.

Pregnancy and lactation

Iron needs rise sharply, particularly after the first trimester. The US RDA is 27 mg per day in pregnancy and 9 mg per day (10 mg for teens) during lactation. Anemia in pregnancy is linked to adverse outcomes for mother and baby, so screening and treatment are routine, with intravenous iron used in the second and third trimesters for severe or non-responsive cases.

Older adults

Iron deficiency in older adults, particularly in men and postmenopausal women, should prompt a search for gastrointestinal blood loss, including malignancy. Anemia in this group is often multifactorial, including chronic disease and kidney disease, so ferritin must be interpreted alongside inflammation markers.

Vegetarians and vegans

Plant-based diets can be adequate if well planned, but the recommended intake is about 1.8 times higher because non-heme iron is less well absorbed. Pairing legumes with vitamin C foods, soaking, sprouting and fermenting grains and legumes, and avoiding tea or coffee with meals help.

Athletes and blood donors

Endurance athletes lose iron through sweat, gastrointestinal bleeding, foot-strike hemolysis and exercise-induced hepcidin elevations. Regular blood donors lose 200–250 mg per donation and may become deficient, particularly premenopausal women and frequent donors. Ferritin monitoring is sensible for both groups.

Chronic disease and surgery

People with chronic kidney disease, heart failure, inflammatory bowel disease, celiac disease, cancer, or a history of gastric bypass often cannot rely on oral iron and need specialist guidance. Inflammation raises hepcidin and traps iron, so ferritin thresholds differ, and WHO recommends higher ferritin cutoffs when inflammation is present.

People with iron overload or hemoglobin disorders

Hemochromatosis, thalassemia major and transfusion-dependent anemias require iron removal rather than iron addition. People with thalassemia trait often have small red cells that resemble iron deficiency but should have ferritin checked before treatment.

Diagnosing deficiency

Serum ferritin is the most useful single test. WHO defines iron deficiency in healthy people as ferritin below 15 µg/L in those aged five and older and below 12 µg/L in younger children, with higher thresholds (70 and 30 µg/L respectively) when infection or inflammation is present. Clinicians also use thresholds such as 30 µg/L in adults. Transferrin saturation below about 20%, low mean corpuscular volume and elevated soluble transferrin receptor support the diagnosis. Hemoglobin cutoffs for anemia vary by age, sex and pregnancy and were revised by WHO in 2024.

23. Quality, Testing and Authentication

Because iron products are inexpensive and widely sold, quality can vary. Reliable products show these features:

•       Clear labeling: elemental iron in mg per serving, the iron compound, and an accurate Daily Value or reference intake percentage.

•       Third-party verification: independent programs such as USP Verified, NSF Certified or similar marks test identity, potency, dissolution and contaminants.

•       Good manufacturing practice: certified facilities, batch numbers and stable expiry dates.

•       Contaminant testing: especially lead, arsenic, cadmium and mercury, with limits aligned to pharmacopeial standards for elemental impurities.

•       Dissolution performance: tablets should disintegrate and dissolve within the specified time. Hard, tightly compressed or heavily coated tablets may pass through poorly.

•       Stability: protection against moisture and oxidation, which convert ferrous to ferric iron over time.

Laboratory methods for authentication include ICP-OES or ICP-MS for iron and trace metals, titration for ferrous content, X-ray diffraction to identify crystalline compounds, and chromatography for co-ingredients. For heme iron, spectrophotometric heme assays and species checks confirm source. Consumers can also check that the product lists a manufacturer, a lot number and a way to contact the company, and clinicians can verify a patient's response with follow-up blood tests.

24. Adulteration and Contamination Risks

Compositional adulteration

Because the iron source determines absorption, substitution of a cheaper, poorly soluble compound for a better one is a quality risk. Examples include use of iron oxide or ferric orthophosphate in place of ferrous salts, underdosing relative to the label, and claiming heme iron or chelate content that is not present. In fortified flour, undissolved iron filings and iron powders can be a quality marker, and magnet-based checks are commonly used in inspection programs to verify fortification.

Heavy-metal and other contamination

Iron ores and some processing streams carry trace metals including lead, cadmium and arsenic, so finished products need testing. A widely cited 2008 JAMA study found that about one fifth of Ayurvedic products purchased online contained detectable lead, mercury or arsenic. This is relevant to traditional iron preparations such as lauha bhasma, whose quality varies by manufacturer and process, and patients should consider standardized, tested products and discuss them with a clinician.

Cookware and environmental sources

Cast iron can add dietary iron, but unregulated cookware made of recycled metals can carry other metals. Water, soil and food contaminants can also affect the safety of fortified foods.

Marketing and label claims

Claims such as "no side effects," "cures anemia" or "gentle on the stomach without testing" are not supported by regulators. Gummies, chewables and liquids may contain less iron than labeled or more than needed, and a pleasant taste can make accidental overdose by children more likely.

25. Regulatory Overview

Regulation of iron differs across regions, but the central themes are labeling of elemental iron, permitted forms, upper limits and protection of children.

•       United States: iron is a dietary supplement ingredient under the Dietary Supplement Health and Education Act. The Daily Value is 18 mg. FDA rules require a child-poisoning warning on iron-containing supplements and unit-dose packaging for products with 30 mg or more of iron per dosage unit. The Institute of Medicine set a UL of 45 mg per day. Enriched flour and cereal products are fortified under federal standards. Intravenous iron and many oral prescription iron products are regulated as drugs.

•       European Union: the Food Supplements Directive (2002/46/EC) lists permitted iron sources, including ferrous carbonate, citrate, gluconate, fumarate, lactate, sulfate, bisglycinate, ferric pyrophosphate and elemental iron. EFSA set population reference values (for example, 11 mg per day for men and 16 mg per day for premenopausal women) but did not set a UL. Authorized health claims, under Regulation 432/2012, include that iron contributes to normal oxygen transport, red blood cell and hemoglobin formation, normal energy metabolism, normal cognitive function, normal immune function and reduction of tiredness and fatigue, with specific conditions of use.

•       United Kingdom: the Expert Group on Vitamins and Minerals identified a safe upper level of about 17 mg per day of supplemental iron for long-term use.

•       India: iron products are regulated under the Food Safety and Standards Authority of India, including its nutraceutical and fortification regulations, while medicinal iron is overseen by drug regulators. National programs provide iron and folic acid supplements through the Anemia Mukt Bharat strategy, and fortified rice, wheat flour, salt and milk are encouraged under national fortification standards.

•       WHO and Codex: WHO publishes guidance on iron supplementation, ferritin use and fortification compounds, and Codex standards guide international trade.

Regulations change and local rules vary, so businesses should verify current requirements before making product claims.

26. Research Gaps

Despite its long history, important questions about iron remain unresolved.

•       Optimal dosing schedules: whether alternate-day, intermittent or low-dose regimens match or surpass daily dosing for clinical outcomes in different populations.

•       Thresholds for deficiency: the best ferritin and transferrin saturation cutoffs across age, sex, pregnancy and inflammation, and the clinical benefit of treating iron deficiency without anemia.

•       Safety in infants and malaria-endemic areas: how to deliver benefits of iron to children while minimizing infection and gut-microbiome risks.

•       Neurocognitive outcomes: long-term effects of early iron deficiency and whether repletion fully reverses them.

•       Comparative effectiveness of forms: large, head-to-head trials of bisglycinate, sucrosomial, heme and polysaccharide products with clinical endpoints.

•       Intravenous iron long-term safety: effects of repeated IV iron, hypophosphatemia, and optimal strategies in heart failure and CKD.

•       Hepcidin-guided care: standardized hepcidin assays and whether personalized dosing based on hepcidin improves results.

•       Genetic variation: how variants in HFE, TMPRSS6 and other genes shape individual risk and response.

•       Heme iron and chronic disease: whether associations with diabetes and colorectal cancer are causal.

•       Population screening: evidence-review groups still differ on routine screening in pregnancy and in young children.

27. Frequently Asked Questions

What is iron and why do I need it?

Iron is an essential mineral that your body uses to make hemoglobin, carry oxygen, produce energy, make DNA and support brain and immune function. Without enough of it, you may develop fatigue, weakness, pale skin, breathlessness and reduced concentration.

How do I know if I am iron deficient?

Only a blood test can confirm it. Ferritin, hemoglobin, transferrin saturation and a complete blood count are the usual tests. Symptoms such as tiredness or hair shedding overlap with many other conditions.

How much iron do I need per day?

For US adults, the RDA is 8 mg for men and women over 50, 18 mg for women aged 19–50, and 27 mg during pregnancy. Vegetarians may need about 1.8 times these amounts.

Which foods are richest in iron?

Liver, oysters, clams, red meat, sardines, lentils, beans, tofu, pumpkin seeds, dark leafy greens and fortified cereals. Heme iron from animal foods is absorbed better than plant iron.

What helps and what blocks iron absorption?

Vitamin C, meat, fish and poultry help. Tea, coffee, calcium, phytates in whole grains and legumes, and some medicines reduce absorption.

Should I take iron every day or every other day?

Absorption studies show a higher fraction absorbed with alternate-day dosing, and it is often better tolerated. Your clinician can recommend a schedule based on your needs.

Which type of iron supplement is best?

Ferrous salts are the standard and most studied. Ferrous bisglycinate and some other forms may be gentler, and intravenous iron is used when oral iron fails. The best form depends on your diagnosis, tolerance and budget.

Can I take iron with vitamin C, calcium or coffee?

Vitamin C is helpful. Calcium, coffee and tea should be spaced one to two hours away from the dose.

What are the common side effects?

Nausea, stomach pain, constipation or diarrhea and dark stools. Lower doses, alternate-day dosing or taking with food often help.

Is it dangerous to take too much iron?

Yes. Acute overdose can be fatal, particularly in children, and chronic excess can damage the liver, heart and pancreas, especially in people with hemochromatosis. Do not exceed the upper limit of 45 mg per day without medical supervision.

Can iron supplements cause weight gain or hair growth?

There is no good evidence that iron causes weight gain. Correcting deficiency may help some forms of hair shedding, but evidence is limited.

Is it safe to take iron during pregnancy?

Yes, at recommended doses and often necessary, but dosing should follow your obstetric provider's advice and testing.

Is it safe for children?

Iron is used in children, but doses are weight based, and unsupervised use is dangerous. Keep every iron product out of reach.

How long does it take to correct iron deficiency?

Hemoglobin usually improves within weeks, but rebuilding stores can take about three to six months or longer.

Do plant-based diets provide enough iron?

They can, with planning. Eat iron-rich plants daily, add vitamin C sources, avoid tea or coffee at meals and consider testing ferritin periodically.

28. Scientific References

The following sources underpin the statements in this guide. Verify page numbers and DOIs against the original publication before citing in regulated or clinical material.

1. Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015;372:1832–1843.

2. Camaschella C. Iron deficiency. Blood. 2019;133:30–39.

3. Pasricha SR, Tye-Din J, Muckenthaler MU, Swinkels DW. Iron deficiency. Lancet. 2021;397:233–248.

4. Zimmermann MB, Hurrell RF. Nutritional iron deficiency. Lancet. 2007;370:511–520.

5. Ganz T. Systemic iron homeostasis. Physiol Rev. 2013;93:1721–1741.

6. Hentze MW, Muckenthaler MU, Galy B, Camaschella C. Two to tango: regulation of mammalian iron metabolism. Cell. 2010;142:24–38.

7. Muckenthaler MU, Rivella S, Hentze MW, Galy B. A red carpet for iron metabolism. Cell. 2017;168:344–361.

8. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306:2090–2093.

9. Krause A, Neitz S, Magert HJ, et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 2000;480:147–150.

10. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2001;276:7806–7810.

11. Kautz L, Jung G, Valore EV, et al. Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat Genet. 2014;46:678–684.

12. Finberg KE, Heeney MM, Campagna DR, et al. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat Genet. 2008;40:569–571.

13. McCance RA, Widdowson EM. Absorption and excretion of iron. Lancet. 1937;230:680–684.

14. Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060–1072.

15. Hallberg L, Hulthén L. Prediction of dietary iron absorption: an algorithm for calculating absorption and bioavailability of dietary iron. Am J Clin Nutr. 2000;71:1147–1160.

16. Hurrell R, Egli I. Iron bioavailability and dietary reference values. Am J Clin Nutr. 2010;91:1461S–1467S.

17. Hallberg L, Rossander-Hulthén L, Brune M, Gleerup A. Inhibition of haem-iron absorption in man by calcium. Br J Nutr. 1993;69:533–540.

18. Morck TA, Lynch SR, Cook JD. Inhibition of food iron absorption by coffee. Am J Clin Nutr. 1983;37:416–420.

19. Cook JD, Reddy MB. Effect of ascorbic acid intake on nonheme-iron absorption from a complete diet. Am J Clin Nutr. 2001;73:93–98.

20. Bovell-Benjamin AC, Viteri FE, Allen LH. Iron absorption from ferrous bisglycinate and ferric trisglycinate in whole maize is regulated by iron status. Am J Clin Nutr. 2000;71:1563–1569.

21. Moretti D, Goede JS, Zeder C, et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood. 2015;126:1981–1989.

22. Stoffel NU, Cercamondi CI, Brittenham G, et al. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. Lancet Haematol. 2017;4:e524–e533.

23. Stoffel NU, Zeder C, Brittenham GM, Moretti D, Zimmermann MB. Iron absorption from supplements is greater with alternate day than with consecutive day dosing in iron-deficient anemic women. Haematologica. 2020;105:1232–1239.

24. Rimon E, Kagansky N, Kagansky M, et al. Are we giving too much iron? Low-dose iron therapy is effective in octogenarians. Am J Med. 2005;118:1142–1147.

25. Tolkien Z, Stecher L, Mander AP, Pereira DIA, Powell JJ. Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS One. 2015;10:e0117383.

26. Peña-Rosas JP, De-Regil LM, Garcia-Casal MN, Dowswell T. Daily oral iron supplementation during pregnancy. Cochrane Database Syst Rev. 2015;(7):CD004736.

27. Pavord S, Daru J, Prasannan N, et al. UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol. 2020;188:819–830.

28. Pasricha SR, Hayes E, Kalumba K, Biggs BA. Effect of daily iron supplementation on health in children aged 4–23 months: a systematic review and meta-analysis of randomised controlled trials. Lancet Glob Health. 2013;1:e77–e86.

29. Sazawal S, Black RE, Ramsan M, et al. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet. 2006;367:133–143.

30. Baker RD, Greer FR; Committee on Nutrition, American Academy of Pediatrics. Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0–3 years of age). Pediatrics. 2010;126:1040–1050.

31. Lozoff B. Early iron deficiency has brain and behavior effects consistent with dopaminergic dysfunction. J Nutr. 2011;141:740S–746S.

32. Jaeggi T, Kortman GAM, Moretti D, et al. Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in Kenyan infants. Gut. 2015;64:731–742.

33. Vaucher P, Druais PL, Waldvogel S, Favrat B. Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: a randomized controlled trial. CMAJ. 2012;184:1247–1254.

34. Houston BL, Hurrie D, Graham J, et al. Efficacy of iron supplementation on fatigue and physical capacity in non-anaemic iron-deficient adults: a meta-analysis of randomised controlled trials. BMJ Open. 2018;8:e019240.

35. Sim M, Garvican-Lewis LA, Cox GR, et al. Iron considerations for the athlete: a narrative review. Eur J Appl Physiol. 2019;119:1463–1478.

36. Anker SD, Comin Colet J, Filippatos G, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009;361:2436–2448.

37. Ponikowski P, Kirwan BA, Anker SD, et al. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure (AFFIRM-AHF). Lancet. 2020;396:1895–1904.

38. Kalra PR, Cleland JGF, Petrie MC, et al. Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN). Lancet. 2022;400:2199–2209.

39. Mentz RJ, Garg J, Rockhold FW, et al. Ferric carboxymaltose in heart failure with iron deficiency (HEART-FID). N Engl J Med. 2023;389:975–986.

40. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure. Circulation. 2022;145:e895–e1032.

41. Allen RP, Picchietti DL, Auerbach M, et al. Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease. Sleep Med. 2018;41:27–44.

42. Auerbach M, Gafter-Gvili A, Macdougall IC. Intravenous iron: a framework for changing the management of iron deficiency. Lancet Haematol. 2020;7:e342–e350.

43. Snook J, Bhala N, Beales ILP, et al. British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults. Gut. 2021;70:2030–2051.

44. Kowdley KV, Brown KE, Ahn J, Sundaram V. ACG clinical guideline: hereditary hemochromatosis. Am J Gastroenterol. 2019;114:1202–1218.

45. Bao W, Rong Y, Rong S, Liu L. Dietary iron intake, body iron stores, and the risk of type 2 diabetes: a systematic review and meta-analysis. BMC Med. 2012;10:119.

46. Fernández-Real JM, Manco M. Effects of iron overload on chronic metabolic diseases. Lancet Diabetes Endocrinol. 2014;2:513–526.

47. Nairz M, Weiss G. Iron in infection and immunity. Mol Aspects Med. 2020;75:100864.

48. Haas JD, Luna SV, Lung'aho MG, et al. Consuming iron biofortified beans increases iron status in Rwandan women after 128 days in a randomized controlled feeding trial. J Nutr. 2016;146:1586–1592.

49. Finkelstein JL, Mehta S, Udipi SA, et al. A randomized trial of iron-biofortified pearl millet in school children in India. J Nutr. 2015;145:1576–1581.

50. Saper RB, Phillips RS, Sehgal A, et al. Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet. JAMA. 2008;300:915–923.

51. Lynch S, Pfeiffer CM, Georgieff MK, et al. Biomarkers of Nutrition for Development (BOND)—Iron review. J Nutr. 2018;148(suppl 1):1001S–1067S.

52. Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academies Press; 2001.

53. EFSA Panel on Dietetic Products, Nutrition and Allergies. Scientific opinion on dietary reference values for iron. EFSA J. 2015;13(10):4254.

54. Expert Group on Vitamins and Minerals. Safe Upper Levels for Vitamins and Minerals. London: Food Standards Agency; 2003.

55. World Health Organization. Guideline on use of ferritin concentrations to assess iron status in individuals and populations. Geneva: WHO; 2020.

56. World Health Organization. Guideline on haemoglobin cutoffs to define anaemia in individuals and populations. Geneva: WHO; 2024.

57. World Health Organization. Guideline: daily iron supplementation in adult women and adolescent girls. Geneva: WHO; 2016.

58. World Health Organization. WHO recommendations on antenatal care for a positive pregnancy experience. Geneva: WHO; 2016.

59. National Institutes of Health, Office of Dietary Supplements. Iron: fact sheet for health professionals.

60. Ministry of Health and Family Welfare, Government of India. Anemia Mukt Bharat: Intensified National Iron Plus Initiative operational guidelines. 2018.

61. Regulation (EC) No 432/2012 establishing a list of permitted health claims made on foods; Directive 2002/46/EC on food supplements; US FDA 21 CFR 101.17(e) and 21 CFR 310.518.

29. Related Content and Product Bridge

This pillar page connects to more specific topics. Link each item below to its dedicated page on your site.

Related guides

•       Iron deficiency symptoms, causes and testing

•       Iron deficiency anemia: diagnosis and treatment pathways

•       Ferritin and transferrin saturation: how to read your results

•       Iron during pregnancy and postpartum recovery

•       Iron for infants, children and teenagers

•       Heme iron versus non-heme iron

•       Iron bisglycinate versus ferrous sulfate

•       Alternate-day iron dosing: what the research shows

•       Iron and vitamin C, vitamin B12, folate, copper and zinc

•       Iron-rich foods and plant-based iron strategies

•       Iron overload and hemochromatosis basics

Product bridge

Readers who finish this guide are typically ready to compare formats, doses and quality markers. A product page should state elemental iron per serving, the iron form, third-party testing status, suggested use, allergen information and the child-safety warning. Suggested placement for calls to action: after section 19 (Available Forms) for form comparison, after section 23 (Quality, Testing and Authentication) for product standards, and in the FAQ for common purchase questions. Add a link to the iron product category or a specific product here: [Insert product or category link].

Disclaimer

This guide is for educational purposes only and is not medical advice. It does not diagnose, treat, cure or prevent any disease. Consult a qualified healthcare professional before starting iron supplementation, particularly if you are pregnant, are giving iron to a child, have a chronic condition or take medicines.